Guidance for Developers of Health Research Reporting Guidelines
article has not abstract
Vyšlo v časopise:
Guidance for Developers of Health Research Reporting Guidelines. PLoS Med 7(2): e32767. doi:10.1371/journal.pmed.1000217
Kategorie:
Guidelines and Guidance
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1000217
Souhrn
article has not abstract
Zdroje
1. GlasziouP
MeatsE
HeneghanC
ShepperdS
2008 What is missing from descriptions of treatment in trials and reviews? BMJ 336 (7659) 1472 4
2. ZhangD
YinP
FreemantleN
JordanR
ZhongN
2008 An assessment of the quality of randomised controlled trials conducted in China. Trials 9 22
3. ScalesCD
NorrisRD
PremingerGM
ViewegJ
PetersonBL
2008 Evaluating the evidence: statistical methods in randomized controlled trials in the urological literature. J Urol 180 1463 1467
4. LaiTYY
WongVWY
LamRF
ChengACO
LamDSC
2008 Quality of reporting of key methodological items of randomized controlled trials in clinical ophthalmic journals. Ophthalmic Epidemiol 14 390 398
5. ChanAW
AltmanDG
2005 Epidemiology and reporting of randomised trials published in PubMed journals. Lancet 365 (9465) 1159 62
6. MoherD
TetzlaffJ
TriccoA
SampsonM
AltmanDG
2007 Epidemiology and reporting characteristics of systematic reviews. PLoS Med 4 e78 doi:10.1371/journal.pmed.0040078
7. MoherD
2007 Reporting research results: a moral obligation for all researchers. Can J Anaesth 54 331 335
8. AltmanDG
SimeraI
HoeyJ
MoherD
SchulzK
2008 EQUATOR: reporting guidelines for health research. Lancet 31 1149 1150
9. MoherD
SimeraI
SchulzK
MillerD
GrimshawJ
Reporting Guidelines for Clinical Research: A Systematic Review. 6th International Congress on Peer Review and Biomedical Publication, Vancouver. Available: http://www.ama-assn.org/public/peer/abstracts-0912.pdf. Accessed 31 October 2009
10. MurphyMK
BlackNA
LampingDL
McKeeCM
SandersonCFB
1998 Consensus development methods, and their use in clinical guideline development. Health Technol Assess 2 1 88
11. O'TooleLB
1997 MRC uses checklist similar to CONSORTs. BMJ 314 1127
12. DavidoffF
BataldenP
StevensD
OgrincG
MooneyS
2008 Publication guidelines for improvement studies in health care: evolution of the SQUIRE Project. Ann Intern Med 149 670 6
13. BoutronI
MoherD
TugwellP
GiraudeauB
PoiraudeauS
2005 Assessing the quality of randomized controlled trials: a checklist to evaluate a report of a nonpharmacological trial: (CLEAN NPT). J Clin Epidemiol 58 123 1240
14. AltmanDG
MoherD
2005 Developing guidelines for reporting healthcare research: scientific rationale and procedures. (In Spanish) Med Clin (Barc) 125 Suppl 1 8 13
15. von ElmE
AltmanDG
EggerM
PocockSJ
GotzschePC
2007 The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med 147 573 7
16. LittleJ
HigginsJ
IoannidisJPA
MoherD
GagnonF
2009 STROBE Extension to Genetic Association studies: STREGA (STrengthening the REporting of Genetic Association studies. PLoS Med 6 e22 doi:10.1371/journal.pmed.1000022
17. BossuytPM
ReitsmaJB
BrunsDE
GatsonisCA
GlasziouPP
2003 for the STARD group. Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD initiative. Ann Intern Med 138 40 44
18. BoutronI
MoherD
AltmanDG
SchulzKF
RavaudP
the CONSORT Group 2005 Reporting of nonpharmacologic treatment interventions: an extension of the CONSORT Statement. Ann Intern Med 148 W-60 W-66
19. DavidsonKW
GoldsteinM
KaplanRM
KaufmannPG
KnatterudGL
2003 Evidence-based behavioral medicine: what is it and how do we achieve it? Ann Behav Med 26 161 71
20. SchulzKF
ChalmersI
HayesRJ
AltmanDG
1995 Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 273 408 412
21. DwanK
AltmanDG
ArnaizJA
BloomJ
ChanAW
2008 Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS ONE 3 e3081 doi:10.1371/journal.pone.0003081
22. De AngelisC
DrazenJM
FrizelleFA
HaugC
HoeyJ
2004 Clinical trial registration: a statement from the International Committee of Medical Journal Editors. Lancet 364 911 912
23. WhittingtonCJ
KendallT
FonagyP
CottrellD
CotgroveA
2004 Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet 363 1341 1345
24. SimeraI
AltmanDG
MoherD
SchulzKF
HoeyJ
2008 Guidelines for reporting health research: the EQUATOR Network's survey of guideline authors. PLoS Med 5 e139 doi:10.1371/journal.pmed.0050139
25. HopewellS
ClarkeM
MoherD
WagerE
MiddletonP
2008 CONSORT for reporting randomized controlled trials in journal and conference abstracts. Lancet 371 281 283
26. TriccoAC
PhamB
BrehautJ
TetroeJ
CappelliM
2009 An international survey suggested that unpublished systematic review exist. J Clin Epidemiol 62 617 623
27. GagnierJJ
BoonH
RochonP
MoherD
BarnesJ
2006 Reporting Randomized, Controlled Trials of Herbal Interventions: An Elaborated CONSORT Statement. Ann Intern Med 144 364 367
28. BossuytPM
ReitsmaJB
BrunsDE
GatsonisCA
GlasziouPP
2003 Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD initiative. Radiology 226 24 28
29. BossuytPM
ReitsmaJB
BrunsDE
GatsonisCA
GlasziouPP
2003 Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD initiative. Clin Chem 49 1 6
30. MoherD
LiberatiA
TetzlaffJ
AltmanDG
the PRISMA Group 2009 Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. PLoS Med 6 e1000097 doi:10.1371/journal.pmed.1000097
31. MoherD
LiberatiA
TetzlaffJ
AltmanDG
the PRISMA Group 2009 Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. Ann Intern Med 151 264 269
32. MoherD
LiberatiA
TetzlaffJ
AltmanDG
the PRISMA Group 2009 Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. Open Med 3 123 130
33. MoherD
LiberatiA
TetzlaffJ
AltmanDG
the PRISMA Group 2009 Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. BMJ 339 332 336
34. MoherD
LiberatiA
TetzlaffJ
AltmanDG
the PRISMA Group 2009 Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. J Clin Epidemiol 62 1006 12
35. MeinertCL
1998 Beyond CONSORT: need for improved reporting standards for clinical trials. JAMA 279 1487 1489
36. AltmanDG
2005 Endorsement of the CONSORT statement by high impact medical journals: survey of instructions for authors. BMJ 330 1056 1057
37. SmidtN
RutjesAW
van der WindtDA
OsteloRW
BossuytPM
2006 The quality of diagnostic accuracy studies since the STARD statement: has it improved? Neurology 67 792 797
38. HopewellS
AltmanDG
MoherD
SchulzKF
2008 Endorsement of the CONSORT Statement by high impact factor medical journals: a survey of journal editors and journal ‘Instructions to Authors’. Trials 9 20
39. PlintAC
MoherD
MorrisonA
SchulzKF
AltmanDG
2006 Does the CONSORT checklist improve the quality of reports of randomized controlled trials: a systematic review. Med J Aust 185 263 267
40. ShojaniaK
SampsonM
JiJ
AnsariMT
DoucetteS
2007 How quickly do systematic reviews go out of date: A survival analysis. Ann Intern Med 147 224 233
41. SmithBA
LeeHJ
LeeJH
ChoiM
JonesDE
2008 Quality of reporting randomized controlled trials (RCTs) in the nursing literature: application of the Consolidated Standards of Reporting Trials (CONSORT). Nurs Outlook 56 31 37
42. PradySL
RichmondSJ
MortonVM
MacPhersonH
2008 A Systematic Evaluation of the Impact of STRICTA and CONSORT Recommendations on Quality of Reporting for Acupuncture Trials. PLoS ONE 3 e1577 doi:10.1371/journal.pone.0001577
43. NarahariSR
RyanTJ
AggithayaMG
BoseKS
PrasannaKS
2008 Evidence-based approaches for the ayurvedic traditional herbal formulations: towards an ayurvedic CONSORT model. J Altern Complement Med 14 769 776
44. MoherD
SchulzKF
AltmanDG
for the CONSORT group 2001 The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials. Lancet 357 1191 1194
45. AltmanDG
SchulzKF
MoherD
EggerM
DavidoffF
2001 The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 134 663 694
46. BossuytPM
ReitsmaJB
BrunsDE
GatsonisCA
GlasziouPP
2003 Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Explanation and Elaboration. Ann Intern Med 138 W1 W12
47. VandenbrouckeJP
von ElmE
AltmanDG
GøtzschePC
MulrowC
2007 The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Epidemiology 18 805 835
48. LiberatiA
AltmanDG
TetzlaffJ
MulrowC
GøtzscheP
2009 The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 6 e1000100 doi:10.1371/journal.pmed.1000100
49. CampbellMK
ElbourneDR
AltmanDG
for the CONSORT group 2004 CONSORT statement: extension to cluster randomised trials. BMJ 328 702 708
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2010 Číslo 2
- Hydroresponzivní krytí v epitelizační fázi hojení rány
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Metamizol v liečbe pooperačnej bolesti u detí do 6 rokov veku
- Co dělat při intoleranci statinů?
- Statiny indukovaná myopatie: Jak na diferenciální diagnostiku?
Najčítanejšie v tomto čísle
- Packages of Care for Attention-Deficit Hyperactivity Disorder in Low- and Middle-Income Countries
- Measuring hsCRP—An Important Part of a Comprehensive Risk Profile or a Clinically Redundant Practice?
- Developing Global Maps of the Dominant Vectors of Human Malaria
- Guidance for Developers of Health Research Reporting Guidelines